Barrett's esophagus: treatments of adenocarcinomas II
The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.
barrett's esophagus adenocarcinoma sentinel node robotic surgery siewert 's classification p53 esophageal cancer gamma probe pet tracer minimally invasive esophagectomy lymphadenectomy robot assisted thoracolaparoscopic esophagectomy sentinel lymph nodes neoadjuvant chemotherapy radiotherapy chemoradiotherapy adenovirus vector prognosis aeg two-stade esophagectomy high risk patients fdg pet scan integrated pet/ct scan chemoradiation residual disease molecular markers gefitinib r0 resection cisplatin 5-fu folfox egfr her2 submucosal invasion multimodality therapy